[1] Martinez-Monge R, Nag S, Nieroda CA, et al. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastic to the liver[J]. Cancer, 1999, 85:1218-1224.
[2] Cormack RA, Kooy H, Tempany CM, et al. Aclinical method for real-time dosimeric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging[J]. Int J Radiat Oncol Biol Phys, 2000, 46(1):207-214.
[3] 岳麓.125I籽源组织间照射在肿瘤治疗中的应用[J].国外医学·放射医学核医学分册,2001,25(1):23-26.
[4] Weaver K, Smith V, Lewis JD, et al. A CT-based computerized treatment planning system for I-125 stereotactic brain implants[J]. Int J Radiat Oncol Biol Phys, 1990, 18(2):445-454.
[5] Bauer-Kirpes B, Sturm V, Schlegel W, et al. Computerized optimization of 125I implants in brain tumors[J]:Int J Radiat Oncol Biol Phys, 1988, 14(5):1013-1023.
[6] Stock RG, Stone NN, Iannuzzi C. Sexual potency following interactive ultrasound-guided braehytherapy for prostate cancer[J]. Int J Radiat Oncol Biol Phys, 1996, 35(2):267-272.
[7] Merrick GS, Butter WM, Dorsey AT, et al. Seed fixity in the prostate/Reriprostic region following brachytherapy[J]. Int J Radiat Oncol Biol Phys, 2000, 46(1):215-240.
[8] Lee WR, McQuellon RP, Harris-Henderson K, et al. A prelininary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer[J]. Int J Radiat Oncol Biol Phys, 2000, 46(1):77-81.
[9] Kumar PP, Patil AA, Syh HW, et al. Role of brachytherapy in the management of the skull base meningioma. Treatment of skull base meningiomas[J]. Cancer, 1993, 71(11):3726-3731.
[10] Meli JA, Dicker CS, Schulz RJ. Computer applications to radioactive-seed:brain-tumor implants[J]. Comput Med Imaging Graph, 1989, 13(3):269-274.
[11] Bentel GC, Halperin EC, Buckley EG.125I embedded in an orbital prosthesis for retreatment of recurrent retinoblastoma[J]. Med Dosim, 1993, 18(1):1-5.